Immunovia AB (publ) Corporate Call Transcript
Ladies and gentlemen, welcome to the Immunovia Press Conference Call. I'm George, the Chorus Call cooperator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Jeff Borcherding, CEO. Please go ahead, sir.
()-&
Thank you very much, and good afternoon, everyone.
Yesterday, we announced a major plan to restructure our operations to focus on our promising next-generation test for the detection of pancreatic cancer. I am excited about the test we have in development and wanted to share additional information about this decision and our path forward.
As we discussed on the first quarter earnings call, we face 3 major challenges. The first is demanding payer requirements for robust clinical data. This clinical data is key to securing reimbursement from U.S. payers and generating revenue.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |